These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30881500)

  • 21. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-Platform Comparison of Four Leading Technologies for Detecting
    Xu T; Kang X; You X; Dai L; Tian D; Yan W; Yang Y; Xiong H; Liang Z; Zhao GQ; Lin S; Chen KN; Xu G
    Theranostics; 2017; 7(6):1437-1446. PubMed ID: 28529628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.
    Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT
    Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
    Wei T; Zhu D; Yang Y; Yuan G; Xie H; Shen R
    PLoS One; 2019; 14(7):e0219129. PubMed ID: 31344053
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Kapeleris J; Kulasinghe A; Warkiani ME; Oleary C; Vela I; Leo P; Sternes P; O'Byrne K; Punyadeera C
    Transl Lung Cancer Res; 2020 Oct; 9(5):1795-1809. PubMed ID: 33209602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistency evaluation of lung adenocarcinoma tissue and circulating tumor cells related gene mutation detection based on multi-site immunomagnetic beads.
    Xue K; Luo B; Li X; Deng W; Zeng C; Zuo C
    J Biomater Appl; 2022 Apr; 36(9):1700-1711. PubMed ID: 35029523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients.
    Dong J; Zhu D; Tang X; Qiu X; Lu D; Li B; Lin D; Zhou Q
    Front Oncol; 2019; 9():1139. PubMed ID: 31737568
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles.
    Liang N; Liu L; Li P; Xu Y; Hou Y; Peng J; Song Y; Bing Z; Wang Y; Wang Y; Jia Z; Yang X; Li D; Xu H; Yu Q; Li S; Hu Z; Yang Y
    J Thorac Dis; 2020 Aug; 12(8):4262-4273. PubMed ID: 32944338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets.
    Kulasinghe A; Kapeleris J; Cooper C; Warkiani ME; O'Byrne K; Punyadeera C
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30889898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma.
    Chauhan A; Pal A; Sachdeva M; Boora GS; Parsana M; Bakshi J; Verma RK; Srinivasan R; Chatterjee D; Maitra A; Ghoshal S
    Front Oncol; 2024; 14():1269211. PubMed ID: 38469233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
    Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of epidermal growth factor receptor gene mutations in different types of non-small cell lung cancer by droplet digital PCR and amplification refractory mutation system].
    Li R; Ye SB; He Y; Wang X; Wu N; Xia QY; Shen Q; Shi SS
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):764-768. PubMed ID: 29136689
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
    Yagi S; Koh Y; Akamatsu H; Kanai K; Hayata A; Tokudome N; Akamatsu K; Endo K; Nakamura S; Higuchi M; Kanbara H; Nakanishi M; Ueda H; Yamamoto N
    PLoS One; 2017; 12(6):e0179744. PubMed ID: 28640869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.
    Isobe K; Hata Y; Kobayashi K; Hirota N; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Shibuya K; Takagi K; Homma S
    Anticancer Res; 2012 Aug; 32(8):3339-44. PubMed ID: 22843912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.